Results from a Australian/New Zealand study using XVIVO’s Heart Technology Published

GOTHENBURG, SE / ACCESSWIRE / November 3, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The results of the clinical trial conducted in Australia and New Zealand on XVIVO's heart technology were earlier this week published in the …